猪肺炎支原体(Mycoplasma hyopneumoniae,Mhp)是引起猪支原体肺炎(Mycoplasma pneumoniae of Swine,MPS)的病原,给养猪业造成巨大的经济损失。由于对具有良好免疫原性的Mhp特异性蛋白缺少深入研究,使得Mhp在致病机制、血清学检测方法和...猪肺炎支原体(Mycoplasma hyopneumoniae,Mhp)是引起猪支原体肺炎(Mycoplasma pneumoniae of Swine,MPS)的病原,给养猪业造成巨大的经济损失。由于对具有良好免疫原性的Mhp特异性蛋白缺少深入研究,使得Mhp在致病机制、血清学检测方法和新型疫苗的研究发展上受到一定限制,从而影响了对MPS的控制。本研究综合Mhp主要粘附因子、膜蛋白及细胞质蛋白等主要抗原蛋白的研究进展,为该病原致病机理研究、建立特异性诊断方法和推动基因工程疫苗发展提供一定的理论基础,对MPS的正确诊断、检测、免疫预防和控制也有重要意义。展开更多
猪肺炎支原体(Mycoplasma hyopneumoniae,Mhp)是猪支原体肺炎(Mycoplsamal pneumonia of swine,MPS)的原发性病原,广泛流行于世界各地,对养猪业造成重大经济损失。MPS发病率高,死亡率低,主要导致猪慢性咳嗽,生长率降低,饲料转换率下降,...猪肺炎支原体(Mycoplasma hyopneumoniae,Mhp)是猪支原体肺炎(Mycoplsamal pneumonia of swine,MPS)的原发性病原,广泛流行于世界各地,对养猪业造成重大经济损失。MPS发病率高,死亡率低,主要导致猪慢性咳嗽,生长率降低,饲料转换率下降,体重增长缓慢。另外,MPS使宿主易感其他呼吸系统病原,从而造成继发感染。由于对具有良好免疫原性的Mhp特异性蛋白缺少深入研究,使得Mhp研究受到一定限制,从而影响了对MPS的控制。文章围绕Mhp主要黏附因子、膜蛋白及细胞质蛋白等主要保护性抗原蛋白予以综述,以期为MPS疾病诊断、监测和相关疫苗研究提供科学依据。展开更多
Background： Plasmodium falciparum malaria remains a major life-threatening disease. Recently, the Plasmodium apoptosis-linked pathogenicity factors （PALPF） have been identified. These antigens PALPF are expressed o...Background： Plasmodium falciparum malaria remains a major life-threatening disease. Recently, the Plasmodium apoptosis-linked pathogenicity factors （PALPF） have been identified. These antigens PALPF are expressed only by P falciparum-infected erythrocytes triggering endothelial cell apoptosis （apoptogenic）. Methods： We designed ten synthetic peptides （PI to P10） from PALPF： PF07 0032, PF10_0226, PFI0130c, PFD0875c and MAL13P1.206, and analyzed their antigenicity with an ELISA method using plasma samples from subjects living in Dienga, Gabon. Results： Four peptides showed good reactivity with human antibodies. The prevalence rate of specific IgG was 61%, 51%, 44% and 34% for P5, P6, P4 and P2, respectively. The median optical density of total IgG anti-P2 was higher than that directed against P4 and P6 （P = 0.009; P = 0.012 respectively）. The prevalence rate oflgG subclasses determined with plasma samples recognizing peptide 5 for IgGl, 2, 3 and 4 isotypes was 69%, 45%, 76% and 62%, respectively. All the subjects had at least one immunoglobulin subclass, while 13 （44%） had both IgG1 and IgG3 antibodies. There was no significant difference in the prevalence rate of anti-P5 IgG1, IgG3 and IgG4. Conclusion： These results warrant further immunogenicity studies of peptides 2, 4, 5 and 6 with a view of a tentative to antimalarial vaccine development.展开更多
文摘猪肺炎支原体(Mycoplasma hyopneumoniae,Mhp)是引起猪支原体肺炎(Mycoplasma pneumoniae of Swine,MPS)的病原,给养猪业造成巨大的经济损失。由于对具有良好免疫原性的Mhp特异性蛋白缺少深入研究,使得Mhp在致病机制、血清学检测方法和新型疫苗的研究发展上受到一定限制,从而影响了对MPS的控制。本研究综合Mhp主要粘附因子、膜蛋白及细胞质蛋白等主要抗原蛋白的研究进展,为该病原致病机理研究、建立特异性诊断方法和推动基因工程疫苗发展提供一定的理论基础,对MPS的正确诊断、检测、免疫预防和控制也有重要意义。
文摘猪肺炎支原体(Mycoplasma hyopneumoniae,Mhp)是猪支原体肺炎(Mycoplsamal pneumonia of swine,MPS)的原发性病原,广泛流行于世界各地,对养猪业造成重大经济损失。MPS发病率高,死亡率低,主要导致猪慢性咳嗽,生长率降低,饲料转换率下降,体重增长缓慢。另外,MPS使宿主易感其他呼吸系统病原,从而造成继发感染。由于对具有良好免疫原性的Mhp特异性蛋白缺少深入研究,使得Mhp研究受到一定限制,从而影响了对MPS的控制。文章围绕Mhp主要黏附因子、膜蛋白及细胞质蛋白等主要保护性抗原蛋白予以综述,以期为MPS疾病诊断、监测和相关疫苗研究提供科学依据。
文摘Background： Plasmodium falciparum malaria remains a major life-threatening disease. Recently, the Plasmodium apoptosis-linked pathogenicity factors （PALPF） have been identified. These antigens PALPF are expressed only by P falciparum-infected erythrocytes triggering endothelial cell apoptosis （apoptogenic）. Methods： We designed ten synthetic peptides （PI to P10） from PALPF： PF07 0032, PF10_0226, PFI0130c, PFD0875c and MAL13P1.206, and analyzed their antigenicity with an ELISA method using plasma samples from subjects living in Dienga, Gabon. Results： Four peptides showed good reactivity with human antibodies. The prevalence rate of specific IgG was 61%, 51%, 44% and 34% for P5, P6, P4 and P2, respectively. The median optical density of total IgG anti-P2 was higher than that directed against P4 and P6 （P = 0.009; P = 0.012 respectively）. The prevalence rate oflgG subclasses determined with plasma samples recognizing peptide 5 for IgGl, 2, 3 and 4 isotypes was 69%, 45%, 76% and 62%, respectively. All the subjects had at least one immunoglobulin subclass, while 13 （44%） had both IgG1 and IgG3 antibodies. There was no significant difference in the prevalence rate of anti-P5 IgG1, IgG3 and IgG4. Conclusion： These results warrant further immunogenicity studies of peptides 2, 4, 5 and 6 with a view of a tentative to antimalarial vaccine development.
